PAM
GSK icon

Palisade Asset Management’s GSK GSK Stock Holding History

Palisade Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93
Closed -$4.01K – 392
2025
Q3 		$4.01K Buy
+93
New +$3.63K ﹤0.01% 429
2024
Q2 		– Sell
-63
Closed -$2.7K – 275
2024
Q1 		$2.7K Buy
+63
New +$2.6K ﹤0.01% 372

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Palisade Asset Management's GSK Position: Q4 2025 in Review

Palisade Asset Management sold out of GSK (GSK) in Q4 2025, closing a stake of 93 shares — an estimated $4.01K sold.

Palisade Asset Management first reported a position in GSK in Q1 2024 and held it in 2 quarters. The position peaked at $4.01K in Q3 2025. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Palisade Asset Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Palisade Asset Management sold 93 GSK shares in Q4 2025, an estimated $4.01K.
  • Palisade Asset Management first reported a position in GSK in Q1 2024 and held it in 2 quarters.
  • Palisade Asset Management's GSK position peaked at $4.01K in Q3 2025.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.